Бегущая строка

QQQA $31.54 -0.4146%
XZW0.L $31.28 -0.0799%
AEME.L $61.29 -0.9175%
TNG.PA $1.76 -2.5499%
S59.SI $2.33 0%
VELA.L $0.02 0%
THCB $10.00 0%
ADV.PA $2.08 0%
RPAD6.SA $6.70 0.1495%
1091.HK $0.50 0%
BCACW $0.55 0%
LRE.L $616.50 1.4815%
BBUD.L $34.29 -3.94958%
SPIR $0.71 -0.6576%
CABO $671.42 0.182%
1327.HK $0.08 0%
CURV $3.42 -3.9326%
AEVA $0.98 -6.2211%
BBDC $7.37 -0.0678%
1936.HK $1.32 2.3256%
SYV $78.52 0%
1341.HK $0.27 -3.6364%
8031.HK $0.20 -0.5%
TRP.L $0.12 6.6667%
KRBN $38.56 -0.3618%
ALDEL.PA $51.20 -1.1583%
RBLX $38.88 -2.5201%
SCJ $69.49 -0.1143%
0106.HK $0.10 0%
NRZ $10.89 0%
MTEKW $0.09 7.5515%
HYMCL $0.04 1.9337%
AREVX $14.57 -0.2055%
MMC $179.95 -0.255%
RMMC.L $150.00 0%
CCNE $16.70 -0.5952%
SHB.L $421.60 0%
BOTJ $9.10 2.3622%
EMB $85.30 -0.5249%
0851.HK $0.30 0%
SBTX.L $17.38 -5.4422%
BIOSU $10.51 -5.0149%
ALDAR.PA $8.60 3.3654%
ARAMI.PA $4.38 -2.0134%
UAMY $0.34 -0.843%
KINZW $0.11 0%
8510.HK $0.05 0%
SLQD $48.53 -0.1946%
EERN $3.37 0%
BWX $22.87 -1.0385%
DENN $10.54 -0.3781%
8480.HK $0.32 0%
NBST $10.29 0.1947%
NBR $88.72 -1.1476%
ISTR $11.50 -0.4329%
OSTR $10.07 0%
GENY $40.69 -0.9761%
SJW $75.68 -0.6563%
0LJE.L $136.89 0.9104%
EMBCV $33.33 0%
NVCT $15.90 5.4045%
0588.HK $0.89 -2.1978%
EAC $10.45 0%
UIHC $4.22 -3.4302%
IRAAW $0.07 0%
0252.HK $3.75 17.1875%
YPF $11.47 -2.4255%
FTCV $10.06 0%
SECO $0.92 -7.61%
MGNS.L $1 816.00 0.8889%
ENSV $0.35 5.5741%
3UKS.L $308.50 -0.8676%
FDS $398.82 -0.3623%
HCM.L $227.00 -2.9915%
TVACW $0.46 0%
ASTSW $1.62 2.5316%
SRNGU $11.97 0%
PEP $195.07 -0.1382%
1143.HK $2.35 0%
ARMR $20.95 -0.1677%
SAH $40.38 -0.5052%
JVA $1.67 1.2121%
0061.HK $0.11 6.5421%
0960.HK $19.82 -1.393%
VLU $139.21 -0.5926%
BCOW $6.49 0.6202%
CARM.PA $14.52 -0.955%
AGCP.L $849.25 -0.0735%
MGEE $77.91 0.6589%
EMIF $22.30 -0.402%
MDRR $5.65 -7.225%
XPDIU $10.57 0%
AGC $11.01 0%
0SD7.L $100.00 0%
OBAS $12.59 0%
JIRE $56.27 -0.2482%
AAAP.L $4.00 0%
FOXT.L $39.55 1.4103%

Хлебные крошки

Акции внутренные

Лого

Clinigen Group plc CLIN.L

$925.00

На 18:02, 12 мая 2023

Ранг: 2

Ранг - это оценка кредитоспособности корпорации.

Ключевые показатели

  • Marketcap

    0.00000000

  • week52high

    948.05

  • week52low

    9.25

  • Revenue

    523600000

  • P/E TTM

    3963

  • Beta

    1.43987100

  • EPS

    22.30000000

  • Last Dividend

    45.62000000

  • Next Earnings Date

    07 мая 2023 г. в 04:15

Описание компании

Clinigen Group plc operates as a pharmaceutical and services company in the United Kingdom, rest of Europe, the United States, South Africa, Australia, and internationally. It operates through Services and Products divisions. The company provides a set of niche and high value services to pharma and biotech clients prior to product launch. It also provides access to critical medicines around the world for patients with unmet needs. In addition, the company provides a portfolio of specialist medicines to service the needs of healthcare professionals and their patients in both licensed and unlicensed markets. Further, it offers Nortriptyline Colonis for the treatment of depressive disorder; Metformin Colonis for the treatment of type 2 diabetes mellitus; Magnesium Chewable Tablets, an oral magnesium supplements for the treatment of patients with chronic magnesium loss; Iloprost, a concentrate for solution for infusion; Glycopyrronium Bromide, an oral solution for the treatment of severe sialorrhoea; Acetylcysteine, an oral solution for the treatment of respiratory disorders associated with thick, viscous, and mucus hypersecretion; Cardioxane that protects the heart against the cardiotoxic effects of anthracyclines; Ethyol, which protect against the harmful effects of chemotherapy medications and radiation treatment; Proleukin for the treatment of kidney cancer; Imukin that is used in chronic granulomatous disease; Totect, a dexrazoxane product; Foscavir, an anti-virals that work by stopping viruses from multiplying in number; and Savene, which is indicated in adults for the treatment of anthracycline extravasation. The company was incorporated in 2008 and is headquartered in Burton-on-Trent, the United Kingdom.

Свежие комментарии

Свежие комментарии

Оставьте свой голос

Оставьте свой голос

Анонимное голосование

Будет ли рост российского рынка к концу года?

  • Да

    87%
  • Нет

    12%

Проголосовал 8 человек